KRAS and cancer: To test whether mutant K‐RAS indeed affects the sensitivity of cancer cells to M1 virus, specific siRNAs to K‐RAS were used to knock down the expression of K‐RAS in HCT‐15 and MIA PaCa‐2 cell lines (Fig. S1), which harbor the mutant K‐RAS (indicated in Table S1).